Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
Chinmayee Sethy, Kunal Goutam, Biswajit Das, et al.
Vascular Pharmacology (2021) Vol. 140, pp. 106865-106865
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 60
The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review
Wafa Bouleftour, Aline Guillot, Nicolas Magné
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 493-501
Open Access | Times Cited: 43
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, et al.
European Urology Open Science (2023) Vol. 53, pp. 31-37
Open Access | Times Cited: 29
Therapeutic prospects of nectin-4 in cancer: applications and value
Kaiyue Li, Yujing Zhou, Maolin Zang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 13
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
Rajalaxmi Pradhan, Subarno Paul, Biswajit Das, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 113, pp. 109257-109257
Closed Access | Times Cited: 32
Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment
S. Acharya, Chanakya Nath Kundu
Cancer Treatment Reviews (2024) Vol. 127, pp. 102749-102749
Closed Access | Times Cited: 6
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
Biswajit Das, Somya Ranjan Dash, Harun Patel, et al.
Phytomedicine (2023) Vol. 117, pp. 154914-154914
Closed Access | Times Cited: 16
Near-Infrared Enhances Antiangiogenic Potentiality of Quinacrine-Gold Hybrid Nanoparticles in Breast Cancer Stem Cells Via Deregulation of HSP-70/TGF-β
Somya Ranjan Dash, Biswajit Das, Chinmay Das, et al.
Nanomedicine (2023) Vol. 18, Iss. 1, pp. 19-33
Closed Access | Times Cited: 11
Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy
N. C. Ganguli, Puja Kumari, Sagarika Dash, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 677, pp. 31-37
Closed Access | Times Cited: 11
Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis
Yali Xu, J. Benedikt, Lin Ye
Cancers (2024) Vol. 16, Iss. 10, pp. 1907-1907
Open Access | Times Cited: 4
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A
Deepika Nayak, Subarno Paul, Chinmay Das, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 609-626
Open Access | Times Cited: 17
A novel portable immuno-device for the recognition of lymphatic vessel endothelial hyaluronan receptor-1 biomarker using GQD–AgNPrs conductive ink stabilized on the surface of cellulose
Ahmad Mobed, Fereshteh Kohansal, Sanam Dolati, et al.
RSC Advances (2023) Vol. 13, Iss. 44, pp. 30925-30936
Open Access | Times Cited: 10
Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer
Jiamei Chen, Bo Luo, Ru Ma, et al.
Diagnostics (2021) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 22
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
Wafa Bouleftour, Paul Sargos, Nicolas Magné
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 181-188
Closed Access | Times Cited: 9
Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
Ha Kyun Chang, Young Hoon Park, Jung-A Choi, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2865-2865
Open Access | Times Cited: 7
Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review
Jakub Kobecki, Paweł Gajdzis, Grzegorz Mazur, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 11
PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells
Chinmayee Sethy, Chanakya Nath Kundu
Toxicology and Applied Pharmacology (2022) Vol. 436, pp. 115860-115860
Closed Access | Times Cited: 10
ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis
Bin Huang, Yao Lu, Zhuona Ni, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 9, pp. 1260-1273
Open Access | Times Cited: 6
High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
Xuequan Wang, Ziming Xing, Huazhong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1371-1388
Open Access | Times Cited: 5
Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review
Jakub Klekowski, Dorota Zielińska, Adriana Hofman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3983-3983
Open Access | Times Cited: 5
Targeted Therapeutic Strategies for Nectin-4 in Breast Cancer: Recent Advances and Future Prospects
Yufei Wang, Guangliang Li, Han-Ying Wang, et al.
The Breast (2024) Vol. 79, pp. 103838-103838
Open Access | Times Cited: 1
Expression of nectin-4 in papillary renal cell carcinoma
Stefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Nectin-4 has emerged as a compelling target for breast cancer
Hui Wang, Dejuan Sun, Jinxia Chen, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176129-176129
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top